VAS
IONS icon

Vestmark Advisory Solutions’s Ionis Pharmaceuticals IONS Stock Holding History

Vestmark Advisory Solutions’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,341
Closed -$567K – 955
2025
Q2 		$567K Buy
+14,341
New +$469K 0.01% 596
2023
Q3 		– Sell
-23,623
Closed -$969K – 652
2023
Q2 		$969K Buy
23,623
+4,556
+24% +$175K 0.04% 454
2023
Q1 		$681K Buy
19,067
+465
+2% +$17.5K 0.03% 522
2022
Q4 		$703K Sell
18,602
-6,597
-26% -$277K 0.03% 502
2022
Q3 		$1.11M Buy
25,199
+1,604
+7% +$67.6K 0.06% 354
2022
Q2 		$874K Buy
23,595
+4,434
+23% +$167K 0.05% 402
2022
Q1 		$710K Buy
19,161
+583
+3% +$19.1K 0.04% 443
2021
Q4 		$565K Sell
18,578
-1,455
-7% -$45.8K 0.03% 509
2021
Q3 		$672K Buy
20,033
+146
+0.7% +$5.5K 0.05% 408
2021
Q2 		$793K Sell
19,887
-6,622
-25% -$259K 0.06% 370
2021
Q1 		$1.19M Buy
26,509
+6,634
+33% +$370K 0.11% 252
2020
Q4 		$1.12M Sell
19,875
-661
-3% -$32.9K 0.13% 221
2020
Q3 		$974K Sell
20,536
-82
-0.4% -$4.55K 0.13% 213
2020
Q2 		$1.22M Sell
20,618
-1,209
-6% -$67.3K 0.19% 151
2020
Q1 		$1.03M Sell
21,827
-788
-3% -$43.9K 0.2% 155
2019
Q4 		$1.37M Sell
22,615
-758
-3% -$45.2K 0.28% 130
2019
Q3 		$1.4M Sell
23,373
-1,000
-4% -$65.2K 0.23% 135
2019
Q2 		$1.57M Buy
24,373
+266
+1% +$18.8K 0.27% 112
2019
Q1 		$1.96M Buy
+24,107
New +$1.56M 0.35% 75

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vestmark Advisory Solutions's IONS Position: Q3 2025 in Review

Vestmark Advisory Solutions sold out of Ionis Pharmaceuticals (IONS) in Q3 2025, closing a stake of 14,341 shares — an estimated $567K sold.

Vestmark Advisory Solutions first reported a position in IONS in Q1 2019 and held it in 19 quarters. The position peaked at $1.96M in Q1 2019. 435 funds tracked by Wall St. Rank hold IONS as of Q3 2025.

  • Vestmark Advisory Solutions reported no remaining Ionis Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Vestmark Advisory Solutions sold 14,341 Ionis Pharmaceuticals shares in Q3 2025, an estimated $567K.
  • Vestmark Advisory Solutions first reported a position in Ionis Pharmaceuticals in Q1 2019 and held it in 19 quarters.
  • Vestmark Advisory Solutions's Ionis Pharmaceuticals position peaked at $1.96M in Q1 2019.
  • 435 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2025.

Based on Vestmark Advisory Solutions's 13F filing for Q3 2025, filed 10 Nov 2025.